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Abstract Overweight and obesity are associated with the
metabolic syndrome (MetS). We studied the association of
weight change over three consecutive 5-year periods with
the number of MetS components in people aged 20–59
years. 5735 participants from the Doetinchem Cohort Study
were included. Weight was measured in round 1 and at each
5-year interval follow-up (round 2, 3 and 4). Weight change
was defined as the absolute weight change between two
consecutive measurements. The number of MetS compo-
nents (assessed in round 2, 3 and 4) was based on the
presence of the following components of the MetS: central
obesity, raised blood pressure, reduced high density lipo-
protein cholesterol and elevated glucose. Associations of
weight change and the number of components of the MetS
were analyzed with Generalized Estimating Equations for
Poisson regression, stratified for 10-year age groups. For
each age group, 1 kg weight gain was positively associated
with the number of components of the MetS, independent of
sex and measurement round. The association was stronger
in 30–39 years (adjusted rate ratio: 1.044; 95%CI: 1.040–
1.049) and smaller in older age groups. Compared to stable
weight ([-2.5 kg and \ 2.5 kg), weight loss (B-2.5 kg)
and weight gain (C2.5 kg) was associated with a lower
and higher rate ratio respectively, for the number of
components of the MetS. Our results support the indepen-
dent association of weight change with the number of MetS
components with a more pronounced association in younger
people.
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Introduction
The prevalence of overweight (body mass index (BMI):
25–30 kg/m2) and obesity (BMI C 30 kg/m2) is increasing
rapidly [1]. In the Netherlands, the prevalence of over-
weight increased from one-third of the adult population in
1981 to about half of the adult population in 2004, and the
prevalence of obesity doubled to 10% [2]. Obesity is
strongly associated with cardiovascular diseases, diabetes
mellitus [3], and the metabolic syndrome (MetS) [4–6].
The MetS predisposes an individual to cardiovascular
morbidity and mortality [8] and diabetes mellitus [9].
Although several definitions of the MetS exist [10], the
main components of the MetS are hypertension, hyper-
glycemia, central obesity, and dyslipidemia (raised tri-
glycerides and/or reduced levels of high density lipoprotein
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cholesterol; HDL-cholesterol) [11]. The etiology of the
MetS is not completely understood, and both abdominal
obesity [12, 13] and insulin resistance [7, 14] have been
suggested as predominant underlying risk factors.
In the 1990s, about one million (14%) Dutch adults were
reported to have the MetS [15]. In the United States, the
prevalence of the MetS has increased in the nineties and is
likely to rise in the future, since the MetS is related to BMI
[4]. Although high weight and BMI are associated with the
MetS and its components [4–6], the patterns of weight
change in relation to the occurrence of the components of
the MetS are less well understood. In several retrospective
and prospective studies, weight gain or an increasing BMI
was associated with the development of the MetS [16–20].
However, those studies were limited to young adults only
[19], were performed in males only [16], or had a relatively
small sample size [17]. Furthermore, some were partly
based upon self-reported weight (recall) [16, 20], which
tends to underestimate real weight [21].
Weight gain tends to be larger in younger individuals
compared to older people [22], whereas the prevalence of the
MetS increases with age [23]. Therefore, it is of importance to
study the relationship between weight change and the com-
ponents of the MetS in a broad age range. Hence, the aim of
the present study is to describe the relationship between
weight change over 5-year periods and the number of com-
ponents of the MetS in a population-based longitudinal cohort
study, for a priori stratified age groups. This relationship will
be studied in the Doetinchem Cohort Study, a population-
based sample of 12,439 men and women aged 20–59 years at
baseline, who have been followed for a period of 16 years.
Methods
Participants and study design
The study design is previously described elsewhere [24]. In
brief, the Doetinchem Cohort Study is a prospective
longitudinal study performed among inhabitants aged
20–59 years of Doetinchem, a town in a rural area in the
Netherlands. The aim of the Doetinchem Cohort Study is to
study the impact of (changes in) lifestyle factors and bio-
logical risk factors on aspects of health. Participants were
randomly selected from an age- and sex-stratified sample
from the civil registries of the town of Doetinchem. At
baseline (1987–1991: round 1), 20155 persons were invited
to visit the municipal health centre to participate in the
‘Monitoring Project on Cardiovascular Disease Risk Fac-
tors’. The participation rate was 62% (12439 participants). In
1993–1998 (round 2), a random sample of 7769 persons was
re-invited. Not all participants could be invited due to logistic
reasons. In 1998–2002 (round 3) and 2003–2007 (round 4),
those who were invited in round 2 were invited again,
excluding those who emigrated, actively withdrew from the
study or died. Interval between the first and second round
was 6 years and interval between each follow-up was
5 years. However, we refer to 5 year intervals for all con-
secutive measurements for simplicity. The response rates for
all follow-up measurements varied between 75% and 80%,
resulting in 6118, 4917 and 4521 participants for round 2, 3
and 4, respectively. In the present analyses, we included the
participants with data on at least one set of weight change
over 5 years and the corresponding number of MetS com-
ponents. For example, one set is the weight change between
round 1 and 2 and the number of MetS components in round
2 (see Fig. 1). Those who reported to have (had) cancer
(N = 401) were excluded from the analysis because of the
potential weight loss associated with this disease. In addition,
those who were pregnant during a measurement round were
excluded for that specific measurement round (N = 16),
resulting in 5735 participants to be included in the analysis.
We certify that all applicable institutional and governmental
regulations concerning the ethical use of human volunteers
were followed during this research. The study was approved
according to the guidelines of the Helsinki Declaration by the
external Medical Ethics Committee of the Netherlands
Organization of Applied Scientific Research (TNO).
Fig. 1 Overview of analyses of 5 year weight change and number of
components of the MetS. Weight change is measured between round
1 and 2 and associated with the number of components of the MetS in
round 2 (white arrows and white box). Weight change between round
2 and 3 was associated with the number of components of the MetS in
round 3 (gray arrows and gray box). Weight change between round 3
and 4 was associated with the number of components of the MetS in
round 4 (black arrows and black box). These three sets of data were
stacked and jointly analyzed with GEE
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Measurements
The study consisted of a standardized measurement of
biological factors by trained personnel during a visit to the
municipal health service. These measurements included
anthropometric measurements, blood pressure measure-
ments and blood sampling. Demographic characteristics,
health-related information, use of medication, and lifestyle
factors were examined by means of a questionnaire, which
was completed at home before the physical examination.
Body weight was measured in all four rounds to the
nearest 100 g on calibrated scales by trained staff, with
participants wearing light indoor clothing with empty
pockets and without shoes. To adjust for light indoor
clothing, 1 kg was subtracted from the measured weight.
Weight change was defined as the absolute change of
weight in a person between two consecutive measurement
rounds. Height was measured to the nearest 0.5 cm.
Central obesity was measured by means of the waist
circumference, which was measured to the nearest 0.5 cm
at the middle of the distance between the lowest rib and the
iliac crest, with participants in standing position wearing
underclothing. Systolic and diastolic blood pressure were
measured twice, with the participant in sitting position.
Systolic pressure was recorded at the appearance of sounds
(first-phase Korotkoff) and diastolic blood pressure was
recorded at the disappearance of sounds (fifth-phase
Korotkoff). The mean value of two measurements was used
in the analysis. Non-fasting levels of HDL-cholesterol were
determined at the Lipid Reference Laboratory of the
Erasmus Medical Centre in Rotterdam, using standardized
enzymatic methods. Non-fasting plasma glucose level was
measured with the hexokinase method [25].
Educational level was assessed as the highest level of
education reached during all measurements and was clas-
sified into three categories: low (intermediate secondary
education or less), medium (intermediate vocational or
higher secondary education) and high (higher vocational
education or university). Smoking status was categorized
as being a smoker, an ex-smoker or a never-smoker.
Alcohol use was based on the number of glasses of alcohol
per day and was categorized in none (0 glasses), light (\1),
moderate (1–3 for men and 1–2 for women) and heavy (C3
for men and C2 for women) alcohol intake. Physical
activity level was assessed with an extensive questionnaire
and dichotomized in those who did and did not comply
with being moderately active for at least 3.5 h per week.
Number of MetS components
The cut-off values of the components of the MetS were
defined according to the 2005 version of the Adult Treat-
ment Panel (ATP) III [26], with some modifications for
glucose. Central obesity was defined as a waist circumfer-
ence of C 102 cm in men and C 88 cm in women,
respectively. High blood pressure was defined as a systolic
blood pressure of C 130 mmHg, or a diastolic blood pres-
sure of C 85 mmHg, or use of antihypertensive medication.
Reduced HDL-cholesterol was defined as \ 1.03 mmol/l in
men and \ 1.3 mmol/l in women or use of cholesterol
lowering medication. Random plasma glucose measure-
ments were used, because no fasting glucose was available.
According to the recommendations of the Dutch College of
General Practitioners (NHG) guidelines [27], a random
glucose of C 7.8 mmol/l was considered as elevated glu-
cose. In addition, those who used medication for diabetes
were also categorized as having elevated glucose.
Blood pressure and HDL-cholesterol were determined in
each round. Waist circumference and glucose were mea-
sured from the second round onwards. Glucose was not
determined in the first year of round 2, therefore the
number of components of the MetS could not be calculated
for the first year of round 2. Triglycerides were not avail-
able. The number of components of the MetS was calcu-
lated for round 2, 3 and 4, and its maximum is four.
Statistical analyses
First, baseline characteristics of the study population were
described. Second, weight and the components of the MetS
were described for each round and per 10-year age group
(20–29 years, 30–39 years, 40–49 years and 50–59 years),
based upon baseline age.
To study the relationship between 5-year changes in
weight and the number of MetS components after these
5 year periods, we included all available sets of weight
change and number of MetS components (see Fig. 1). To
adjust for the correlation between repeated measurements
in a person, we used generalized estimating equations
(GEE). GEE analyses can also deal with unequal numbers
of measurements and with unequally spaced observations.
Based upon the correlations of the metabolic parameters
over time, we chose the exchangeable correlation structure
as the working correlation structure. The number of com-
ponents of the MetS was analyzed using Poisson regres-
sion, which provides a rate ratio.
The relationship between weight change and the number
of components of the MetS was analyzed in two ways: (1)
weight change over 5 years as a continuous determinant,
and (2) weight change over 5 years as a categorical deter-
minant; i.e. three groups: stable weight (less than 2.5 kg
weight loss and less than 2.5 kg weight gain ([ -2.5 kg
and \ 2.5 kg)), weight loss (at least 2.5 kg weight loss
(B -2.5 kg)), and weight gain (at least 2.5 kg weight gain
(C 2.5 kg)), with stable weight as the reference group. The
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2.5 kg cut-off point reflects a weight gain of approximately
0.5 kg per year. For both analyses, the first model was
adjusted for sex, round, and weight in the preceding round
(Model A), and the second model was further adjusted for
educational level, smoking status, alcohol use, physical
activity and height (Model B). Both analyses were a priori
stratified for 10-year age groups, based on age in round 1.
Effect modification of sex, weight in the preceding
round, and educational level was examined by testing the
significance of the interaction term with weight change in
the model. Effect modifiers are only mentioned when they
were consistently found in at least three of the four age
groups.
Because weight and waist circumference are correlated
and waist circumference is one of the components of the
MetS, the GEE analyses were repeated after removing
central obesity from the components of the MetS in addi-
tional analyses.
Finally, the association of weight change with the con-
tinuous values of the individual metabolic components
waist circumference, systolic and diastolic blood pressure,
HDL-cholesterol, and glucose were studied with linear
GEE analyses. Effect modification and confounding were
studied similar to the other GEE analyses.
Statistical significance was set at p \ 0.05. All analyses
were carried out in SAS 9.1 for Windows (SAS Institute
Inc., Cary, NC, USA) and the GEE analyses were per-
formed with the procedure GENMOD.
Results
Table 1 presents the baseline characteristics of the study
population. A total of 2735 men (47.7%) and 3000 women
(52.3%) were included in the analysis. For each round and
10-year age group, weight and MetS parameters are
described in Table 2. The average weight increased over
time. Waist circumference and blood pressure tended to
worsen over the age groups and during follow-up, whereas
the change in HDL-cholesterol and glucose over the age
groups and over time was less clear. The number of com-
ponents of the MetS increased during follow-up. For
instance, the prevalence of three or more components was
10.1% in the second round compared to 17.8% in the fourth
round. The most common MetS component for all age
groups and measurements combined was hypertension
(55%), followed by central obesity (39%), reduced HDL-
cholesterol (31%) and elevated random glucose (5%) (data
not shown). The average number of MetS components
(range 0–4) in round 2 was 0.75, 0.91, 1.24, and 1.61 for
the age groups 20–29 years, 30–39 years, 40–49 years, and
50–59 years, respectively.
In Fig. 2, the percentage individuals with weight loss
(B -2.5 kg), stable weight ([-2.5 kg and \ 2.5 kg) and
weight gain (C 2.5 kg) over 5 years are presented per age
group. The percentage of persons with weight gain became
smaller with increasing age. The participants aged
20–29 years did not only have the highest percentage
weight gainers (53%), but also the highest absolute
increase in weight (6.8 kg ± 4.0) in the weight gain group.
Furthermore, average weight change over 5 years is larger
in younger age groups (20–29 years: 3.1 ± 5.4 kg) than in
older age groups (50–59 years: 1.0 ± 4.2 kg).
Table 3 (Model A) presents the regression coefficients
(adjusted for sex, measurement round and weight in the
preceding round) for the association of 1 kg weight
change over 5 years with the number of components of
the MetS. The a priori stratification for age groups was
appropriate because significant interactions with age were
found. For all age groups, 1 kg weight change was pos-
itively associated with the number of components, with
rate ratios ranging from 1.025 (95% CI: 1.021–1.029) in
the 50–59 years old to 1.042 (95% CI: 1.038–1.046) in
the 30–39 years old. The latter rate ratio can be inter-
preted as follows: an increase in weight of 1 kg in 5 years
was associated with 1.042 (95% CI: 1.038–1.046) times
more components of the MetS. Adjustment for educa-
tional level, smoking status, alcohol use, physical activity
and height (Model B) did not materially change the
relationship between weight change and the number of
components of the MetS. Significant effect modification
was present for weight change and weight in the pre-
ceding round: the association of weight change with the
Table 1 Baseline characteristics of the study sample (Data are mean
(SD) or number (%))
Characteristics Total (N = 5735)
Age (years) 39.5 (10.1)
Sex
Men 2735 (47.7%)
Women 3000 (52.3%)
Educational level
Low 2779 (48.5%)
Moderate 1687 (29.4%)
High 1266 (22.1%)
Smoking status
Current smoker 1947 (34.0%)
Former smoker 1649 (28.8%)
Never smoker 2134 (37.2%)
Physical activitya
Active 2557 (54.8%)
Not active 2111 (45.2%)
a Measured at T2
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number of components of the MetS was slightly less
strong in persons with a higher weight in the preceding
round.
Table 4 presents the association of weight loss and
weight gain over a period of 5 years with the number of
components of the MetS. For all age groups, weight loss
Table 2 Weight and components of the MetS per age group and total group for each round (N = 5735) (Data are mean (SD) or number (%))
Age groupa Round 1 (N = 5735) Round 2 (N = 5592) Round 3 (N = 4464) Round 4 (N = 4153)
Age (years) 39.5 (10.1) 45.6 (10.1) 50.1 (9.9) 54.7 (9.8)
Sex (men) 2735 (47.7%) 2660 (47.6%) 2154 (48.3%) 1996 (48.1%)
Weight (kg) 20–29 years 70.1 (12.5) 74.0 (13.7) 77.1 (14.0) 78.9 (15.2)
30–39 years 72.0 (12.6) 75.2 (13.3) 77.5 (13.9) 78.9 (14.3)
40–49 years 74.1 (12.5) 76.6 (13.2) 78.5 (13.6) 78.6 (13.8)
50–59 years 75.3 (11.8) 76.6 (12.2) 77.9 (12.3) 77.9 (13.0)
Total 72.9 (12.5) 75.7 (13.2) 77.8 (13.5) 78.6 (14.1)
Waist circumference (cm) 20–29 years – 85.4 (10.8) 88.8 (11.0) 91.2 (11.9)
30–39 years – 88.7 (10.9) 91.5 (11.2) 93.7 (11.3)
40–49 years – 92.3 (11.1) 94.8 (11.5) 96.2 (11.6)
50–59 years – 95.2 (10.6) 97.1 (11.0) 98.7 (11.2)
Total – 90.5 (11.4) 93.0 (11.6) 94.9 (11.7)
Systolic blood pressure (mmHG) 20–29 years 118 (13) 118 (13) 119 (14) 125 (15)
30–39 years 118 (13) 121 (14) 125 (15) 131 (16)
40–49 years 121 (15) 127 (16) 131 (17) 139 (19)
50–59 years 128 (16) 135 (19) 140 (19) 147 (19)
Total 121 (15) 125 (17) 129 (18) 135 (19)
Diastolic blood pressure (mmHG) 20–29 years 73 (9) 76 (9) 77 (10) 82 (10)
30–39 years 75 (10) 79 (10) 81 (11) 85 (10)
40–49 years 79 (10) 82 (11) 83 (11) 87 (10)
50–59 years 81 (11) 83 (11) 83 (11) 86 (10)
Total 77 (10) 80 (11) 81 (11) 85 (10)
HDL-cholesterol (mmol/l) 20–29 years 1.26 (0.29) 1.37 (0.36) 1.34 (0.35) 1.39 (0.36)
30–39 years 1.25 (0.30) 1.37 (0.37) 1.37 (0.39) 1.44 (0.42)
40–49 years 1.26 (0.33) 1.40 (0.41) 1.39 (0.41) 1.45 (0.43)
50–59 years 1.22 (0.31) 1.35 (0.37) 1.33 (0.38) 1.40 (0.41)
Total 1.25 (0.31) 1.37 (0.38) 1.36 (0.39) 1.43 (0.41)
Random glucose (mmol/l)b 20–29 years – 5.0 (1.0) 5.1 (0.9) 4.9 (0.9)
30–39 years – 5.2 (1.0) 5.3 (1.1) 5.2 (1.2)
40–49 years – 5.5 (1.6) 5.7 (1.7) 5.4 (1.5)
50–59 years – 5.8 (2.1) 5.8 (1.9) 5.6 (1.6)
Total – 5.4 (1.5) 5.5 (1.5) 5.3 (1.4)
Number of components of the MetSc
0 2204 (38.5%) 1606 (31.1%) 1123 (25.5%) 687 (16.6%)
1 2611 (45.6%) 1889 (36.6%) 1447 (32.9%) 1367 (33.1%)
2 916 (16.0%) 1146 (22.2%) 1181 (26.9%) 1341 (32.5%)
3 – 465 (9.0%) 559 (12.7%) 621 (15.0%)
4 – 59 (1.1%) 87 (2.0%) 117 (2.8%)
a Age group is based on age of the participant in round 1. Number of participants per age group in round 1: 20–29 years: N = 1007;
30–39 years: N = 1873; 40–49 years: N = 1689; 50–59 years: N = 1166
b The glucose measurements were based on N = 5250 in the second round, because glucose was not determined in the first year of round 2
c The components of the MetS were: central obesity (waist circumference of C102 cm in men and C88 cm in women respectively), raised blood
pressure (systolic blood pressure of C130 mmHg, or diastolic blood pressure of C85 mmHg, or use of antihypertensive medication), reduced
HDL-cholesterol (\1.03 mmol/l in men and \1.3 mmol/l in women respectively or use of cholesterol medication), and elevated glucose level
(random glucose of C 7.8 mmol/l or use of medication for diabetes). The maximum number of components of the MetS in round 1 was two
because waist circumference and glucose were not determined in the first round
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was associated with a decreased number of components
and weight gain was associated with an increased number
of components, compared to the stable weight group. Not
surprisingly, these associations were the strongest in those
aged 20–29 years because their absolute weight loss and
weight gain was the largest. In persons aged 20–29 years,
weight gain was associated with 1.305 (95% CI: 1.212–
1.405) times the number of components of those who
remained relatively stable in weight. In persons aged
50–59 years, C 2.5 kg weight gain was related to only
1.141 (95% CI: 1.101–1.182) times the number of com-
ponents of those in the stable weight group. Similar dif-
ferences between the age groups were found for the
association of weight loss and stable weight. In the fully
adjusted model (Model B), the effect of weight loss and
gain remained present and became slightly more pro-
nounced. There was significant effect modification between
weight change category and weight in the preceding round
for the weight gain group compared to the weight stable
group, but not for the weight loss group. The strength of the
association of weight gain with the number of MetS
components was less in people with higher baseline weight.
Additional analysis
Weight and waist circumference are correlated and waist
circumference is one of the MetS components, thus part of
the dependent variable. Therefore, we repeated the analy-
ses by excluding central obesity from the MetS compo-
nents, resulting in a maximum of three MetS components.
The association of 1 kg weight change in a 5-year period
with the number of MetS components was weaker in the
analysis without central obesity than in the analysis
including central obesity as part of the MetS components,
but still statistically significant for all age groups (rate
ratios ranging from 1.015 to 1.033), indicating that the
association of weight change with the number of MetS
components does not depend solely on its association with
waist circumference. A similar pattern of weaker but sig-
nificant associations was observed for the weight gain/
weight loss analyses.
Finally, we studied the associations of 1 kg weight
change over 5 years with the individual metabolic com-
ponents with longitudinal linear regression analysis. One
Fig. 2 Percentage individuals (height bar) and mean absolute weight
change in kg over 5 years (number in the bar) averaged over the four
measurement rounds per weight change category for each age group
Table 3 Association of 1 kg weight increase over 5 years with the
number of components of the MetS per age group
Model A Model B
Rate ratio 95% CI Rate ratio 95% CI
20–29 years 1.038 1.031–1.045 1.038 1.030–1.046
30–39 years 1.042 1.038–1.046 1.044 1.040–1.049
40–49 years 1.031 1.027–1.034 1.033 1.029–1.037
50–59 years 1.025 1.021–1.029 1.025 1.021–1.030
Table presents rate ratios from longitudinal Poisson regression. Model
A is adjusted for: sex, measurement round and weight in the pre-
ceding round. Model B is additionally adjusted for: educational level,
smoking status, alcohol use, physical activity and height
Table 4 Association of weight loss and gain over 5 years with the number of components of the MetS per age group
Weight loss (B -2.5 kg) Weight gain (C2.5 kg)
Model A Model B Model A Model B
Rate ratio 95% CI Rate ratio 95% CI Rate ratio 95% CI Rate ratio 95% CI
20–29 years 0.773 0.685–0.872 0.768 0.680–0.867 1.305 1.212–1.405 1.318 1.224–1.418
30–39 years 0.790 0.738–0.845 0.783 0.729–0.840 1.282 1.234–1.333 1.310 1.258–1.363
40–49 years 0.809 0.768–0.853 0.800 0.758–0.844 1.208 1.169–1.249 1.224 1.183–1.267
50–59 years 0.888 0.843–0.934 0.873 0.828–0.920 1.141 1.101–1.182 1.132 1.091–1.175
Table presents rate ratios from Poisson regression. Reference group is the stable weight group ([-2.5 kg and\2.5 kg). Model A is adjusted for:
sex, measurement round and weight in the preceding round. Model B is additionally adjusted for: educational level, smoking status, alcohol use,
physical activity and height
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kg weight change was related to an increase in waist cir-
cumference (b: 0.838 cm; 95% CI: 0.821–0.856), systolic
blood pressure (b: 0.432 mmHg; 95% CI: 0.379–0.486),
diastolic blood pressure (b: 0.355 mmHg; 95% CI: 0.318–
0.392) and glucose (b: 0.014 mmol; 95% CI: 0.009–0.020)
and a decrease in HDL-cholesterol (b: -0.011 mmol; 95%
CI: -0.012 to -0.011) in the fully adjusted model (model
B). No consistent effect modification was observed for the
individual metabolic components.
Discussion
In this prospective cohort study, weight change over a
5-year period was associated with increased number of
components of the MetS, independent from sex, measure-
ment round and other cardiovascular risk factors. Com-
pared to those who remained relatively stable in weight,
weight gain (C 2.5 kg) was related to an increase in the
number of components of the MetS, whereas weight loss
(B -2.5 kg) was related to a decrease in the number of
components. The association of weight change and the
number of MetS components was stronger in younger than
in older people. Furthermore, there was negative effect
modification with weight in the preceding round, indicating
that the association of weight change and the number of
MetS components in those already high in weight was
slightly weaker.
As weight gain is an important public health concern,
more insight into the effect of weight change on metabolic
components is needed. Because weight change and the
development of MetS components varies with age [22, 23],
we studied the effect of weight change on the number of
MetS components for different age groups. In the present
study, in all adult age groups, weight gain predisposed an
individual to increased number of MetS components,
compared to those who maintained a stable weight. Similar
associations were observed by Hillier et al. [18], who
showed in French individuals aged 30–64 years that larger
weight gain was associated with higher rates of both
developing and maintaining the MetS than smaller weight
gain. In addition, in the CARDIA study, a prospective
study in persons aged 18–30 years at baseline, a stable
BMI over time was associated with a smaller incidence of
the MetS compared to a rise in BMI over time, regardless
of the baseline BMI [19]. Furthermore, in the longitudinal
study of Ferreira et al. [17], it was found that persons with
the MetS at age 36 had a more marked increase of BMI
from the age of 21 onwards.
In our study, weight gain was positively related with the
individual MetS components waist circumference, systolic
and diastolic blood pressure, and glucose level and nega-
tively with HDL-cholesterol. This is in accordance with the
findings of several other longitudinal studies in adults with
different duration of follow-up (range: 2–11 years)
[18, 28–31]. Weight gain was related to unfavorable
changes in waist circumference [18], blood pressure,
hypertension [18, 28–31], and lipid profile [18, 30, 31]. For
glucose level, Norman et al. [31] found a positive associ-
ation between weight change and fasting glucose level.
Czernichow et al. [29] did not observe this association,
possibly due to the short follow-up time of 2 years in this
study. Similar to our results, Hillier et al. [18] found that
weight change was most strongly related to waist circum-
ference out of all individual metabolic components.
It is well known that components of the MetS tend to
worsen with age [19] and that the prevalence of the MetS
increases with age [32, 33]. Our study is in line with these
findings, because the number of components of the MetS
increased with age. In our analyses with weight change as a
continuous variable, those aged 30–39 years showed the
largest rate ratio for the association of weight change and
number of MetS components. Since absolute weight gain
was larger in younger adults, it might be important to
prevent weight gain in younger adults. In the weight loss/
weight gain analyses, the higher rate ratio observed in
young adults is probably largely the result of the higher
absolute weight change in young adults.
In our study we found that those who lost weight had a
reduction in the number of components compared to the
participants who had a stable weight. The favorable effect
of weight loss on the metabolic risk profile has also been
shown in weight loss intervention studies in obese adults
[34]. However, weight loss and weight loss maintenance
are hard to achieve [35]. Recent studies demonstrated an
association of repeated weight loss [36] and weight fluc-
tuation [20] with the MetS. Therefore, weight stabilization
may be a more important public health goal [19]. Weight
gain prevention in adults can be accomplished by pre-
venting a positive energy balance by stimulating physical
activity and reducing energy intake, and by focusing on the
environment to make the healthy choice the easiest choice
[37].
Because no standard definition of weight loss, stable
weight and weight gain exists [38], we set the cut-off value
of weight change on 2.5 kg. Sensitivity analyses with cut-
off values of 1 and 4 kg confirmed our findings that the
association of weight change with the number of compo-
nents of the MetS was stronger in younger age groups (data
not shown).
What distinguishes the present study from earlier ones is
that the relationship between weight change and the MetS
is quantified in a broad age group (20–59 years) with a
follow-up of 16 years. Another strength is that weight
change was not self-reported, but measured by trained
personnel. Further strengths are its large sample size, the
Weight change and components of the metabolic syndrome 131
123
prospective design, and the availability of up to four
measurements per individual. The response rate of the
follow-up measurements was also relatively high (C 75%
from the second round onwards). Finally, by using GEE
analysis all data are effectively used.
One of the limitations is selective loss to follow-up.
Compared to the participants included in this study, those
who were lost to follow-up were more often lower edu-
cated, current smokers and of younger age. In addition,
baseline BMI and baseline blood pressure were higher in
those who were lost to follow-up, whereas baseline HDL-
cholesterol was lower. No difference was found for sex,
weight and alcohol consumption at baseline (data not
shown). Our study population is therefore not representa-
tive for the Dutch population, and the results might not be
generalizable to young, low educated persons with a rela-
tive adverse cardiovascular risk profile. Another important
limitation is the lack of information about triglycerides.
Therefore, it was not possible to determine the relationship
between weight change and the MetS. Instead, our study
included four metabolic components, derived from the
2005 version of the ATP III definition of the MetS [26] and
looked at the number of MetS components. In addition,
glucose level was measured non-fasting. This might be less
accurate since food intake affects the level of blood glucose
[39]. We compensated for this by using a higher cut-off
value reflecting fasting glucose levels, as reported in Rutten
et al. [27].
While it seems that certain components of the MetS are
prone to cluster, the exact components and cut-off values
of the MetS differ over the existing definitions [12]. Fur-
thermore, the number of MetS components in round 2 is
somewhat larger in older age groups than in younger
people. The different rate ratio’s observed for the age
groups might also reflect a ceiling effect. However, as the
number of metabolic syndrome components at baseline in
the oldest age group is not extremely high, we feel that the
ceiling effect does not completely account for the observed
difference in rate ratio’s between age groups.
With the dichotomization of the components informa-
tion is lost. Analyses with the continuous values of the
individual components showed associations in the expected
direction for each separate component and strengthened
our findings.
In sum, weight gain is positively associated with the
number of components of the MetS, whereas weight loss is
negatively associated with this number. Our study shows
that the effect of weight change on the number of MetS
components is different for various age groups. Prevention
of weight gain might be relevant in younger adults in
particular, for whom the association of weight change with
the number of MetS components is the strongest and the
weight gain is the largest.
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